Skip to main content
. 2022 May 6;12(12):4424–4431. doi: 10.1016/j.apsb.2022.04.019

Figure 2.

Figure 2

The overall spectrum of drugs reported to liver injury. (A) The drug category spectrum of L-ADR. (B) The proportion of L-ADR reports of pre-known hepatotoxicity group and new-finding group. (C) The proportions of pre-known and new-finding groups categorized by H/TM and CP agents.